Keywords: EMA; European Medicines Agency; FDA; The Food and Drug Administration; NPH; neutral protamine hagedorn; PROBE; prospective, randomised, open, blinded endpoint; Type 1 diabetes; Severe hypoglycemia; HbA1c; Human insulin; Insulin analogs; Personalized thera
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: WHO; World Health Organization; GDM; gestational diabetes mellitus; PG; plasma glucose; CVP; pre-analytical variation; CVI; within-subject biological variation; CVA; analytical variation; ADA; American Diabetes Association; HAPO; Hyperglycaemia and Advers
Keywords: amorphous; nanoparticles; nanocrystalline; solubility; stability; dissolution; solid state; calorimetry; X-ray diffraction; bioavailability; ACN; amorphous chitin nanoparticles; API; active pharmaceutical ingredient; APTES; 3-aminopropyltriethoxysilane; B
Keywords: CLA; curved linear array; CRE; carbapenem-resistant enterobacteriaceae; cRN; culturing registered nurses; ETO; ethylene oxide; FDA; U.S. Food and Drug Administration; GNB; gram-negative bacilli; HLD; high-level disinfection; MDR; multidrug resistant;
Keywords: acute cough; common cold; pharmacologic and nonpharmacologic treatment; CACC; cough associated with the common cold; CHEST; American College of Chest Physicians; FDA; Food and Drug Administration; NSAID; nonsteroidal anti-inflammatory drug; OTC; over the
Keywords: ACT; activated clotting time; AF; atrial fibrillation; ASAP; Aspirin Plavix Feasibility Study; CAP; Continued Access Protocol; CT; computed tomographic; CV; Cardiovascular; CVD; Cardiovascular disease; DAPT; dual anti-platelet therapy; DAT; device associa
Keywords: filter retrieval; hematology; intervention; IVC filter; laser; FDA; Food and Drug Administration; IVC; inferior vena cava;
Keywords: AL; sodium alginate; CpHCl; ciprofloxacin hydrochloride; FDA; Food and Drug Administration; PCL; polycaprolactone; PLA; polylactic acid; PGLA; poly(lactic-co-glycolic acid); PEO; polyethylene glycol, poly(ethylene oxide); PVA; poly(vinyl alcohol); PVP; po
Keywords: Trans-fatty acids; Metabolic syndrome; Prevalence ratio; Epidemiology; NHANES; BMI; body mass index; CI; confidence interval; FDA; Food and Drug Administration; HDL; high-density lipoprotein; HEI-2010; Healthy Eating Index-2010; NHANES; National Health
Keywords: Nausea; Vomiting; Fullness; Bloating; b.i.d; twice daily; DGSSD; Diabetic Gastroparesis Symptom Severity Diary; FDA; US Food and Drug Administration; GCSI-DD; Gastroparesis Cardinal Symptom Index-Daily Diary; GEBT; gastric emptying breath test; PRO; patie
Keywords: ACEI; angiotensin converting enzyme inhibitors; ACCF; American College of Cardiology Foundation; AHA; American Heart Association; A-HeFT; African-American Heart Failure Trial; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; ARNI; angio
Keywords: APC; antigen-presenting cell; BMA; butyl methacrylate; C16; 2-(R/S)-hexadecanoic acid; (C18)2; N,N-dioctadecyl succinamic acid; CFA; complete Freund's adjuvant; CuAAC; copper-catalyzed azide-alkyne cycloaddition; DLS; dynamic light scattering; ELISA; enzy
Keywords: DISINFECTS Study; Surveillance; Endoscopy; Non-outbreak Setting; CFU; colony-forming units; dHLD; double high-level disinfection; FDA; US Food and Drug Administration; HLD; high-level disinfection; HLD/ETO; standard high-level disinfection followed by et
Receptor-based screening assays for the detection of antibiotics residues - A review
Keywords: AMP; ampicillin; APH; (3')-IIa (Aminoglycoside 3'-O phosphoryl transferase II a; ATP; adenosine triphosphate; AOAC; Association of Official Analytical Chemists; CE; capillary electrophoresis; DHPPP; 6-hydroxymethyl-7,8-dihydropterin pyrophosphate; DHPS; d
Keywords: Gastroesophageal Reflux; Nissen Fundoplication; Proton Pump Inhibitors; BMI; body mass index; FDA; Food and Drug Administration; GEJ; gastroesophageal junction; GERD; gastroesophageal reflux disease; HRQOL; health-related quality of life; LES; lower esoph
Keywords: Thyroid hormone metabolites; Tandem mass spectrometry; 3-Iodothyronamine; Iodothyronine; CLIA; Chemiluminescence immunoassays; 3,5-T2; 3,5-Diiodo-L-thyronine; 3,3â²-T2; 3,3'-Diiodo-L-thyronine; ELISA; Enzyme-linked immunosorbent assay; FDA; Food and Dr
Keywords: Inflammatory Bowel Disease; Pregnancy; AntiâTumor Necrosis Factor; CI; confidence interval; DBP; dibutyl phthalate; FDA; US Food and Drug Administration; IBD; inflammatory bowel disease; OR; odds ratio; OTIS; Organization of Teratology Information Speci
Keywords: Drug development; Precision medicine; Phase III trials; Biomarker; FDA;
Keywords: cTnT; Cardiac troponin T; CPHPC; R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]pyrrolidine-2-carboxylic acid; EGCG; epigallocethechin-3-gallate; FLC-diff; difference between involved and uninvolved serum free light chain; FDA; Food and Drug Administ
Keywords: ADMET; absorption, distribution, metabolism, excretion, toxicity; AHR; aryl hydrocarbon receptor; AUC; area under the curve; BVU; (E)-5-(2-bromovinyl) uracil; CAR; constitutive androstane receptor; cMOAT; Canalicular multispecific organic anion transporte
Keywords: API; active pharmaceutical ingredient; BE; bioequivalence; CLSM; confocal laser scanning microscopy; DDS; drug delivery system; ELISA; enzyme-linked immunosorbent assay; EMA; European Medicines Agency; FDA; U.S. Food & Drug Administration; FITC; fluoresce
Anticancer properties of sodium selenite in human glioblastoma cell cluster spheroids
Keywords: 3D culture; Three dimension cell culture; ABC; ATP-binding cassette; ANOVA; analysis of variance; AOBS; Acousto-Optical Beam Splitter; APMA; amino-phenyl mercuric acetate; BBB; blood brain barrier; BSA; bovine serum albumin; CA9; carbonic anhydrase 9; DME
Keywords: AIF; apoptosis inducing factor; Ang; angiopoietin; AP-1; activator protein-1; APEX; Assessment of Proteasome Inhibition for Extending Remissions; ATP; adenosine-5â²-triphosphate; BiPN; bortezomib-induced peripheral neuropathy; CiPN; chemotherapy-induced
Keywords: Arthroplasty; Joint replacement; Medical alloys; Review; Surface treatment; 3DP; 3D Printing; ALM; additive layer manufacturing; AM; additive manufacturing; ARB; accumulative roll bonding; ASTM; American Society of Testing Materials; AWJ; abrasive water j
Keywords: MCAo; middle cerebral artery occlusion; MRI; magnetic resonance imaging; DWI; diffusion-weighted imaging; ADC; apparent diffusion coefficient; FDA; Food and drug administration; MMP; matrix metalloproteinases; TTC; 2,3,5-triphenyltetrazolium chloride; HED
Capillary electrophoresis in the context of drug discovery
Keywords: ACE; affinity capillary electrophoresis; AGP; α-acid glycoprotein; AH; adrenaline hydrochloride; AIμEA; automatic micro-enzyme assay; AL; amlodipine; AT; antithrombin III; Bag3; Bcl2-associated anthanogene 3; BGE; background electrolyte; CM; chylomicron
Keywords: Narcolepsy; Cataplexy; Orexin; Hypocretin; Neurodegeneration; Animal models; 5-HT; 5-hydroxytrytamine (serotonin); α1; noradrenergic alpha 1 receptor; α2; noradrenergic alpha 2 receptor; ACh; acetylcholine; Atax; orexin/ataxin-3 transgenic; BAC; bacteri
Keywords: LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
Recent advancements in the development of anti-tuberculosis drugs
Keywords: ADRs; adverse drug reactions; AG; arabinogalactan; AhpE; alkylhydroperoxide reductase E; Alr; d-alanine racemase; AMP; adenosine monophosphate; AnPRT; anthranilate phosphoribosyltransferase; ATP; adenosine triphosphate; BTZ; benzothiazinone; CADD; compute
Keywords: ER; endoplasmic reticulum; ERT; enzyme replacement therapy; FDA; U.S. Food and Drug Administration; LD; lysosomal disease; M6P; mannose-6-phosphate; M6PR; mannose-6-phosphate receptor; MPS; mucopolysaccharidosis; NPC; Type C Niemann-Pick disease; NPD; Typ
Keywords: Regulation; Innovation; FDA; Medical devices;
Keywords: AE; adverse event; AML; acute myeloid leukemia; APC; anaphase promoting complex; CLL; chronic lymphocytic leukemia; CPC; chromosomal passenger complex; CR; complete response; CRi; complete remission with incomplete blood count recovery; FDA; Food and Drug
Keywords: IKBKAP; inhibitor of kappa light polypeptide gene enhancer in B-cells; IKAP; IKK complex-associated protein; FD; familial dysautonomia; US; United States; CN; cranial nerve; CNS; central nervous system; MRI; magnetic resonance imaging; iPSC; induced pluri
Keywords: ACC; American College of Cardiology; acLDL; acetylated-low density lipoprotein; AHA; American Heart Association; ALL; acute lymphoblastic leukemia; ANG1; angiopoietin 1; ATMP; Advanced Therapy Medicinal Product; BM; bone marrow; BMSC; bone marrow-derived
Keywords: Caffeine; Systematic review; Safety; Pregnancy; Coffee; Behavior; ADHD; attention deficit hyperactivity disorder; AHRQ; Agency for Healthcare Research and Quality; BMC; bone mineral content; BMD; bone mineral density; BMI; body mass index; CDC; US Centers
Keywords: Regenerative medicine; Guideline; FDA; PMDA; EMA; Harmonization;
Keywords: Antibiotics; FDA; Market exclusivity;
Keywords: ADHD; attention hyperactive disorder; AKT; protein kinase B; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Bcl-2; B-cell lymphoma 2; BDNF; brain derived neurotrophic factor; Css; Steady state plasma concentration; D1; type 1 dopamine recept
Keywords: Electronic cigarette; tobacco-use cessation; fire; mouth injuries; CT; Computed tomographic; e-cigarettes; Electronic cigarettes; FDA; Food and Drug Administration;
Keywords: funding; resources; SBIR; small business; STTR; CRP; Commercialization Readiness Pilot; FDA; Food and Drug Administration; NHLBI; National Heart, Lung, and Blood Institute; NIH; National Institutes of Health; SBIR; Small Business Innovation Research; STTR
Keywords: urinary incontinence, stress; Medicare; aged; suburethral slings; treatment outcome; FDA; Food and Drug Administration; SUI; stress urinary incontinence;
Keywords: Regulatory framework; Quality evaluation system; National reference panel; HIV diagnostics; China; HIV; Human immunodeficiency virus; AIDS; Acquired Immuno-Deficiency Syndrome; NAT; nucleic acid tests; ELISA; enzyme-linked immunosorbent assay; NIFDC; Nati
Keywords: CDF; Cancer Drugs Fund; CMS; Centers for Medicare and Medicaid Services; FDA; Food and Drug Administration; R&D; research and development;
Keywords: actinic prurigo; itch; prurigo nodularis; pruritus; thalidomide; FDA; Food and Drug Administration; NCS; nerve conduction studies; REMS; Risk Evaluation and Mitigation Strategy;
Keywords: apremilast; cost per responder; cost-effectiveness; indirect comparison; methotrexate; moderate to severe psoriasis; number needed to treat; Psoriasis Area and Severity Index; AAD; American Academy of Dermatology; CI; confidence interval; FDA; Food and Dr
Keywords: CRC; colorectal cancer; SNP; single nucleotide polymorphism; CNV; copy number variant; GWAS; genome-wide association studies; GO; gene ontology; BP; biological process; CAM; cell adhesion molecule; CIN; chromosomal instability; MSI; microsatellite instabi
Keywords: aPR; adjusted prevalence ratio; ENDS; electronic nicotine delivery system; FDA; Food and Drug Administration; IRB; institutional review board; NATS; National Adult Tobacco Survey; Electronic cigarettes; Adult; Nicotine;
Keywords: BMI; Body mass index; DPP-4; Dipeptidyl peptidase IV; FDA; Food and Drug Administration; GLP-1; Glucagon-like peptide 1; Hb; Hemoglobin; INGAP; Islet cell neogenesis-associated protein; RYGB; Roux-en-Y gastric bypass; T2D; Type 2 diabetes;
Keywords: AER; automated endoscope reprocessor; ASGE; American Society for Gastrointestinal Endoscopy; FDA; U.S. Food and Drug Administration; HLD; high-level disinfection;
Keywords: equipment design; new device development strategies; research design; research ethics committees; United States Food and Drug Administration; CDRH; Center for Devices and Radiological Health; CMS; Centers for Medicare & Medicaid Services; EFS; early feasi